The Greater Cannabis Company, Inc. (GCAN) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for The Greater Cannabis Company, Inc. (GCAN).

Download OTCGems on Google Play Download OTCGems on the App Store

Equity Overview

Price & Market Data

Price: $0.324

Daily Change: +$0.0012 / 0.37%

Daily Range: $0.29 - $0.388

Market Cap: $274,031

Daily Volume: 4,376

Performance Metrics

1 Week: 105.2%

1 Month: 362.4%

3 Months: 531.0%

6 Months: -17.00%

1 Year: -70.84%

YTD: 64.94%

Company Details

Employees: 1

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson's disease, Alzheimer's disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.

Selected stocks

LIR LIFE SCIENCES CORP (BBCMF)

Skycap Investment Holdings Inc. (LIMFF)

BeMetals Corp. (BMTLF)